FDA revises provisions of the proposed rule
date:Jul 27, 2015
(at 3 percent), and annualized net benefits of $1.9 billion (at 7 percent) and $2.1 billion (at 3 percent). This represents an annual increase in net benefits from the original PRIA's estimates of approximately $200 million per year.Show citation box.

We summarize the annualized costs and benefits (over a 20-year period discounted at both 3 percent and 7percent) of the previous and revised proposed rules in the following table.
21/21 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/05 03:45